US Stock MarketDetailed Quotes

Sagimet Biosciences (SGMT)

Watchlist
  • 7.610
  • -0.420-5.23%
Close May 1 16:00 ET
  • 7.570
  • -0.040-0.53%
Post 19:26 ET
247.97MMarket Cap-4.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sagimet Biosciences (SGMT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
4.47%56.89M
-40.84%10.77M
-15.19%14.33M
12.62%11.93M
126.56%19.87M
66.32%54.45M
92.21%18.2M
78.82%16.9M
50.05%10.59M
29.61%8.77M
Selling and administrative expenses
11.40%17.84M
1.31%4.03M
8.35%4.6M
9.38%4.68M
29.01%4.52M
23.51%16.01M
4.44%3.98M
-5.45%4.25M
79.59%4.28M
53.91%3.51M
-General and administrative expense
11.40%17.84M
1.31%4.03M
8.35%4.6M
9.38%4.68M
29.01%4.52M
23.51%16.01M
4.44%3.98M
-5.45%4.25M
79.59%4.28M
53.91%3.51M
Research and development costs
1.59%39.05M
-52.63%6.73M
-23.10%9.73M
14.81%7.25M
191.56%15.34M
94.39%38.44M
151.34%14.22M
155.20%12.65M
35.01%6.31M
17.27%5.26M
Operating profit
-4.47%-56.89M
40.84%-10.77M
15.19%-14.33M
-12.62%-11.93M
-126.56%-19.87M
-77.14%-54.45M
-92.21%-18.2M
-126.81%-16.9M
-50.05%-10.59M
-29.61%-8.77M
Net non-operating interest income expense
-34.16%5.85M
-39.97%1.2M
-37.54%1.43M
-37.72%1.54M
-21.04%1.69M
210.73%8.89M
51.75%1.99M
108.49%2.28M
808.46%2.47M
1,088.33%2.14M
Non-operating interest income
-34.16%5.85M
-39.97%1.2M
-37.54%1.43M
-37.72%1.54M
-21.04%1.69M
210.73%8.89M
51.75%1.99M
108.49%2.28M
808.46%2.47M
1,088.33%2.14M
Other net income (expense)
Income before tax
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
Income tax
Net income
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
Net income continuous Operations
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
Minority interest income
Net income attributable to the parent company
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
Basic earnings per share
-8.97%-1.58
42.00%-0.29
11.11%-0.4
-28.00%-0.32
-143.48%-0.56
45.49%-1.45
-40.45%-0.5
-28.57%-0.45
18.30%-0.25
22.57%-0.23
Diluted earnings per share
-8.97%-1.58
42.00%-0.29
11.11%-0.4
-28.00%-0.32
-143.48%-0.56
45.49%-1.45
-40.45%-0.5
-28.57%-0.45
18.30%-0.25
22.57%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 4.47%56.89M-40.84%10.77M-15.19%14.33M12.62%11.93M126.56%19.87M66.32%54.45M92.21%18.2M78.82%16.9M50.05%10.59M29.61%8.77M
Selling and administrative expenses 11.40%17.84M1.31%4.03M8.35%4.6M9.38%4.68M29.01%4.52M23.51%16.01M4.44%3.98M-5.45%4.25M79.59%4.28M53.91%3.51M
-General and administrative expense 11.40%17.84M1.31%4.03M8.35%4.6M9.38%4.68M29.01%4.52M23.51%16.01M4.44%3.98M-5.45%4.25M79.59%4.28M53.91%3.51M
Research and development costs 1.59%39.05M-52.63%6.73M-23.10%9.73M14.81%7.25M191.56%15.34M94.39%38.44M151.34%14.22M155.20%12.65M35.01%6.31M17.27%5.26M
Operating profit -4.47%-56.89M40.84%-10.77M15.19%-14.33M-12.62%-11.93M-126.56%-19.87M-77.14%-54.45M-92.21%-18.2M-126.81%-16.9M-50.05%-10.59M-29.61%-8.77M
Net non-operating interest income expense -34.16%5.85M-39.97%1.2M-37.54%1.43M-37.72%1.54M-21.04%1.69M210.73%8.89M51.75%1.99M108.49%2.28M808.46%2.47M1,088.33%2.14M
Non-operating interest income -34.16%5.85M-39.97%1.2M-37.54%1.43M-37.72%1.54M-21.04%1.69M210.73%8.89M51.75%1.99M108.49%2.28M808.46%2.47M1,088.33%2.14M
Other net income (expense)
Income before tax -12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M
Income tax
Net income -12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M
Net income continuous Operations -12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M
Minority interest income
Net income attributable to the parent company -12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M-0.64%-6.63M
Basic earnings per share -8.97%-1.5842.00%-0.2911.11%-0.4-28.00%-0.32-143.48%-0.5645.49%-1.45-40.45%-0.5-28.57%-0.4518.30%-0.2522.57%-0.23
Diluted earnings per share -8.97%-1.5842.00%-0.2911.11%-0.4-28.00%-0.32-143.48%-0.5645.49%-1.45-40.45%-0.5-28.57%-0.4518.30%-0.2522.57%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -